CTOs on the Move

Aquor Health Care Svc

www.aquor.com

 
Aquor Health Care Svc is a Woodbridge, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.aquor.com
  • 74 Main St
    Woodbridge, NJ USA 07095
  • Phone: 732.726.1688

Executives

Name Title Contact Details

Similar Companies

Windsor House Inc

Windsor House Inc is a Girard, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Millennium Pharmacy Systems

Millennium Pharmacy Systems is a pharmacy services provider to the long-term care industry.

VisuWell

VisuWell is the leader in patient-centered, innovative, and affordable virtual care solutions. The VisuWell platform is an easy-to-use, enterprise-ready, browser-deployed technology increasing healthcare access for health systems, ambulatory care organizations, and payors. VisuWell offers patients and providers a comprehensive telehealth experience for consults, triage, telemedicine visits, and remote patient monitoring over a wide variety of use cases and environments. VisuWell enables care organizations to utilize their own provider networks to offer easy-to-access, high-quality care. The VisuWell platform creates a tailored virtual experience accommodating 35+ use cases serving thousands of locations and helping millions of people to see healthcare differently.

Integrated Health Plan Inc

Integrated Health Plan Inc is a Saint Petersburg, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Fractyl Laboratories

At Fractyl, we are focused on improving the health of people with Type 2 diabetes. We`ve created an innovative clinical procedure based on new insights into the root cause of the disease. We are currently engaged in clinical trials designed to prove that our innovative procedure can dramatically improve glucose control and reduce the need for additional medications. Our mission is to set people free from the daily burdens of Type 2 diabetes management, empower physicians with a safe and reliable therapeutic treatment, and lower the tremendous human and financial costs of diabetic complications for patients, hospitals, and payers.